Morocco's Laprophan initial public offering drew 15.3 billion dirhams ($1.5 billion) in orders, making it seven times oversubscribed on the Casablanca Stock Exchange. The listing is the largest on the local bourse this year, combining new and existing shares. The transaction highlights strong investor appetite for pharmaceutical assets in the North African market.

Expansion Plans and Financials